Lambertus A. Kiemeney

92.3k total citations · 9 hit papers
471 papers, 21.5k citations indexed

About

Lambertus A. Kiemeney is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lambertus A. Kiemeney has authored 471 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Surgery, 136 papers in Pulmonary and Respiratory Medicine and 103 papers in Oncology. Recurrent topics in Lambertus A. Kiemeney's work include Bladder and Urothelial Cancer Treatments (132 papers), Urinary and Genital Oncology Studies (88 papers) and Prostate Cancer Diagnosis and Treatment (78 papers). Lambertus A. Kiemeney is often cited by papers focused on Bladder and Urothelial Cancer Treatments (132 papers), Urinary and Genital Oncology Studies (88 papers) and Prostate Cancer Diagnosis and Treatment (78 papers). Lambertus A. Kiemeney collaborates with scholars based in Netherlands, United States and United Kingdom. Lambertus A. Kiemeney's co-authors include Katja K.H. Aben, J. Alfred Witjes, F.M.J. Debruyne, Martine Ploeg, Anke Richters, Jack A. Schalken, J.A. Witjes, James W.F. Catto, Dorine W. Swinkels and André L. M. Verbeek and has published in prestigious journals such as The Lancet, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Lambertus A. Kiemeney

449 papers receiving 20.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Risk Factors of Urothelial Bladder Cancer

2012 1.5k citations Lambertus A. Kiemeney et al. profile →
Bladder cancer: Epidemiology, staging and grading, and diagnosis

2005 787 citations Lambertus A. Kiemeney et al. profile →
The Epidemiology of Renal Cell Carcinoma

2011 763 citations Lambertus A. Kiemeney et al. profile →
The present and future burden of urinary bladder cancer in the world

2009 717 citations Martine Ploeg, Katja K.H. Aben et al. profile →
The global burden of urinary bladder cancer: an update

2019 595 citations Anke Richters, Katja K.H. Aben et al. profile →
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

2018 533 citations Lambertus A. Kiemeney et al. profile →
DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

2003 532 citations Inge M. van Oort, Herbert F.M. Karthaus et al. profile →
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors

2023 222 citations Lambertus A. Kiemeney et al. profile →
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice

2023 167 citations Alina Vrieling, Antoine G. van der Heijden et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lambertus A. Kiemeney Netherlands	71	7.9k	5.2k	5.2k	3.9k	3.8k	471	21.5k
David E. Neal United Kingdom	77	4.3k 0.5×	7.6k 1.5×	8.4k 1.6×	3.0k 0.8×	5.7k 1.5×	559	22.3k
Teuvo L.J. Tammela Finland	69	3.7k 0.5×	12.7k 2.5×	6.3k 1.2×	4.5k 1.2×	4.1k 1.1×	669	24.3k
Susan Groshen United States	94	11.7k 1.5×	6.2k 1.2×	9.1k 1.8×	2.8k 0.7×	12.0k 3.2×	479	31.8k
Eric A. Klein United States	88	6.0k 0.8×	19.7k 3.8×	5.0k 1.0×	2.2k 0.6×	4.8k 1.3×	733	29.8k
Yair Lotan United States	87	19.7k 2.5×	11.2k 2.2×	6.9k 1.3×	5.8k 1.5×	5.1k 1.4×	717	31.4k
John T. Wei United States	73	4.9k 0.6×	13.3k 2.6×	4.7k 0.9×	5.7k 1.5×	3.4k 0.9×	378	23.7k
Fritz H. Schröder Netherlands	79	4.2k 0.5×	17.5k 3.4×	3.8k 0.7×	1.8k 0.5×	4.3k 1.1×	501	22.7k
Neil Fleshner Canada	71	4.6k 0.6×	8.4k 1.6×	3.3k 0.6×	1.6k 0.4×	3.4k 0.9×	661	16.5k
Hendrik Van Poppel Belgium	82	6.5k 0.8×	19.0k 3.7×	6.7k 1.3×	2.3k 0.6×	3.3k 0.9×	567	24.9k
David F. Penson United States	72	5.9k 0.8×	11.9k 2.3×	2.2k 0.4×	3.6k 0.9×	6.9k 1.8×	432	23.7k

Countries citing papers authored by Lambertus A. Kiemeney

Since Specialization

Citations

This map shows the geographic impact of Lambertus A. Kiemeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lambertus A. Kiemeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lambertus A. Kiemeney more than expected).

Fields of papers citing papers by Lambertus A. Kiemeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lambertus A. Kiemeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lambertus A. Kiemeney. The network helps show where Lambertus A. Kiemeney may publish in the future.

Co-authorship network of co-authors of Lambertus A. Kiemeney

This figure shows the co-authorship network connecting the top 25 collaborators of Lambertus A. Kiemeney. A scholar is included among the top collaborators of Lambertus A. Kiemeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lambertus A. Kiemeney. Lambertus A. Kiemeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bangma, Chris H., Maarten J. Bijlsma, Alfons C.M. van den Bergh, et al.. (2025). External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study. BMC Cancer. 25(1). 149–149. 1 indexed citations

Oosterwijk‐Wakka, Jeannette, Loes F.M. van der Zanden, Lambertus A. Kiemeney, et al.. (2024). Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma. Neoplasia. 60. 101108–101108. 1 indexed citations

Krens, Stefanie D., Stefan Böhringer, Ingrid M.E. Desar, et al.. (2024). Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer. British Journal of Clinical Pharmacology. 91(2). 297–305. 1 indexed citations

Ausems, Margreet G.E.M., Lambertus A. Kiemeney, Harm H.E. van Melick, et al.. (2024). Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 28(3). 789–794. 1 indexed citations

Aben, Katja K.H., et al.. (2023). Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort. European Urology Oncology. 7(4). 829–837. 3 indexed citations

Richters, Anke, Debbie Robbrecht, Richard P. Meijer, et al.. (2023). Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort. European Urology Open Science. 59. 50–54. 1 indexed citations

Richters, Anke, Joost L. Boormans, Michiel S. van der Heijden, et al.. (2021). Overall survival of patients receiving cisplatin or carboplatin for primary metastatic urothelial carcinoma of the bladder: A contemporary Dutch nationwide cohort study. European Urology Open Science. 33. S391–S391. 1 indexed citations

Potjer, Thomas P., Sander Bollen, Mar Rodríguez‐Girondo, et al.. (2020). Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. Journal of Medical Genetics. 58(11). 760–766. 6 indexed citations

Klein, Marieke, Ditte Demontis, Anders D. Børglum, et al.. (2020). Contribution of Intellectual Disability–Related Genes to ADHD Risk and to Locomotor Activity in Drosophila. American Journal of Psychiatry. 177(6). 526–536. 17 indexed citations

10.

Cuypers, Maarten, Hilde Tobi, Michiel ten Hove, et al.. (2020). Disparities in cancer‐related healthcare among people with intellectual disabilities: A population‐based cohort study with health insurance claims data. Cancer Medicine. 9(18). 6888–6895. 31 indexed citations

11.

Galesloot, Tessel E., et al.. (2019). Cigarette Smoking and the Risk of Cutaneous Melanoma: A Case-Control Study. Dermatology. 236(3). 228–236. 24 indexed citations

12.

Witjes, J. Alfred, et al.. (2019). The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life. BMJ Open. 9(10). e030396–e030396. 10 indexed citations

13.

Schuurman, Melinda S., L.C.G. van den Einden, Leon F.A.G. Massuger, et al.. (2013). Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. European Journal of Cancer. 49(18). 3872–3880. 116 indexed citations

14.

Heilmann‐Heimbach, Stefanie, Dale R. Nyholt, F.F. Brockschmidt, et al.. (2013). No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia. Queensland's institutional digital repository (The University of Queensland). 2 indexed citations

15.

Coenen, Marieke J. H., Martine Ploeg, Mascha M.V.A.P. Schijvenaars, et al.. (2008). Allelic Imbalance Analysis Using a Single-Nucleotide Polymorphism Microarray for the Detection of Bladder Cancer Recurrence. Clinical Cancer Research. 14(24). 8198–8204. 6 indexed citations

16.

Schultz, Iman J., Kenneth Wester, Huub Straatman, et al.. (2006). Prediction of recurrence in Ta urothelial cell carcinoma by real‐time quantitative PCR analysis: A microarray validation study. International Journal of Cancer. 119(8). 1915–1919. 19 indexed citations

17.

Aben, Katja K.H., J. Alfred Witjes, J.A.A.M. van Dijck, et al.. (2000). Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin. European Journal of Cancer. 36(18). 2385–2389. 7 indexed citations

18.

Keech, M., R. Fourcade, Richard Hobbs, et al.. (1998). The UrEpiK Study: A cross-sectional survey of benign prostatic hyperplasia, urinary incontinence and male erectile dysfunction, prostatitis and interstitial cystitis in the UK, France, the Netherlands and Korea. Radboud Repository (Radboud University). 3. 178–179. 12 indexed citations

19.

Kiemeney, Lambertus A., et al.. (1997). Incidentie en behandeling van prostaatcarcinoom in de regio van het Integraal Kankercentrum Amsterdam, 1989-1994. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 141. 495–495. 4 indexed citations

20.

Koper, N.P., et al.. (1996). Ovarian cancer incidence (1989–1991) and mortality (1954–1993) in the Netherlands. Obstetrics and Gynecology. 88(3). 387–393. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact